BASAL CELL CARCINOMA
Clinical trials for BASAL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new BASAL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for BASAL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental combo therapy shows promise in advanced cancers, but trial halted early
Disease control TerminatedThis study tested whether injecting vidutolimod directly into tumors plus giving cemiplimab through a vein could shrink cancers that have spread. The trial included 77 people with several types of advanced cancer. Unfortunately, the study was stopped early, so we have less inform…
Matched conditions: BASAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Chemo patch for skin cancer shows promise in early trial
Disease control TerminatedThis early-stage study tested a new way to deliver the chemotherapy drug doxorubicin directly into basal cell skin cancer using tiny dissolving needles on a patch. The goal was to find a safe dose and see if it could completely remove the cancer. The study included 13 adults with…
Matched conditions: BASAL CELL CARCINOMA
Phase: PHASE1 • Sponsor: SkinJect, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
AI mole checker tested at home – but trial stops early
Diagnosis TerminatedThis study tested whether a device called the Sklip System, which uses artificial intelligence, could help people at home decide if a mole might be skin cancer. Only one person took part before the study was stopped early. The goal was to see if the AI could match or beat standar…
Matched conditions: BASAL CELL CARCINOMA
Phase: NA • Sponsor: OHSU Knight Cancer Institute • Aim: Diagnosis
Last updated Jun 27, 2026 08:07 UTC